Kevin Nelson is the Chief Procurement Officer at BD (Becton, Dickinson and Company), a medical technology company based in Franklin Lakes, New Jersey. His responsibilities include overseeing all third-party spend, including direct and indirect.
“I've been in the procurement profession for a number of years, starting my career in the high-tech industry and evolving into roles within the biotechnology arena before leading strategic sourcing at C. R. Bard, a medical device company that BD acquired about six years ago,” he says.
BD is one of the world's largest medical technology companies. Its purpose is ‘advancing the world of health’ by improving medical discovery, diagnostics and the delivery of care. “Roughly 90% of patients coming into a clinical setting in the United States are going to use a BD product,” says Nelson. Products vary from well-known medical devices such as needles, syringes and blood collection tubes to sophisticated electromechanical devices, diagnostic instruments and reagents.
Here, he tells us how BD mitigates supply chain risks through advanced technologies and creates a socially responsible supply chain.